4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-005484
Options or other derivatives
- Chief Executive Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Mazumdar Claire Chief Executive Officer | 2026-02-02 | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | D | ||
Loading xslF345X05/wk-form4_1770241022.xml…